A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : sHLA-G / soluble human leukocyte antigen-G

[Related PubMed/MEDLINE]
Total Number of Papers: 46
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   sHLA-G  (>> Co-occurring Abbreviation)
Long Form:   soluble human leukocyte antigen-G
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Detection of serum soluble HLA-G levels in patients with acute ischemic stroke: A pilot study. AIS, ELISA, FIV, HD, HT
2020 Soluble HLA-G expression levels and HLA-G/irinotecan association in metastatic colorectal cancer treated with irinotecan-based strategy. 5-FU, LV, mCRC
2020 The P2X7 Receptor 489C>T Gain of Function Polymorphism Favors HHV-6A Infection and Associates With Female Idiopathic Infertility. HHV-6A, IL-1alpha, P2X7R
2019 Quantitative analysis of the sHLA-G protein in seminal plasma. ART, ELISA
2019 The Phenotype and Secretory Activity of Adipose-Derived Mesenchymal Stem Cells (ASCs) of Patients with Rheumatic Diseases. ASCs, ESR, HD, ICAM, IFN, IL, LIF, MSCs, PGE2, RD, TGF, TNF, TSG, VCAM
2019 [The Role of Soluble HLA-G in the Vertical Transmission of Toxoplasma gondii]. dNK
2017 A meta-analysis of the impact of human leukocyte antigen-G on the outcomes of IVF/ICSI. CI, OR, ORs
2017 Evaluation of sHLA-G levels in serum of patients with prostate cancer identify as a potential of tumor marker. PSA
2017 Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients. BM-MSCs, MSCs, PBMCs, PBS, SLE, SLEDAI, Treg, UC-MSCs
10  2017 [Serum soluble HLA-G, soluble CD30 is correlated to the time after transplantation in renal transplant recipients]. sCD30
11  2016 Association between decreased plasma levels of soluble human leukocyte antigen-G and severe pre-eclampsia. CI, OR
12  2016 The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets. hDP-MSCs, HGF, IDO, IFNG, IL, MSCs, PGE2, TGFB1
13  2015 Evaluation of Soluble Human Leukocyte Antigen-G (sHLA-G) Isoforms and Regulatory T Cells in Relapsing-Remitting Multiple Sclerosis. HLA, MS, NK, RRMS
14  2015 Soluble HLA-G in pregnancies complicated by autoimmune rheumatic diseases. ---
15  2014 Serum-soluble HLA-G is associated with specific IgE in patients with allergic rhinitis and asthma. AA, AR, Th
16  2014 Temporal variation in soluble human leukocyte antigen-G (sHLA-G) and pregnancy-associated plasma protein A (PAPP-A) in pregnancies complicated by gestational diabetes mellitus and in controls. GDM, PAPP-A
17  2013 Embryonic soluble human leukocyte antigen-G as a marker of embryo competency in assisted reproductive technology for Chinese women. ART, ESs
18  2013 Post-transplant increase in soluble human leukocyte antigen-G associated with non-severe cardiac allograft vasculopathy. CAV, IVUS
19  2013 The effect of the biochemical marker soluble human leukocyte antigen G on pregnancy outcome in assisted reproductive technology--a multicenter study. GES, IVF
20  2012 Clinical relevance of sHLA-G-mediated with better graft acceptance in early posttransplantation. ---
21  2012 Maternal soluble human leukocyte antigen-G levels in pregnancies complicated by foetal intrauterine growth restriction with and without preeclampsia. IUGR
22  2012 Serum human leukocyte antigen-G and soluble interleukin 2 receptor levels in acute lymphoblastic leukemic pediatric patients. ALL, sIL-2R
23  2012 Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma. AFP, AUC, HBV, HCC
24  2012 The concentrations of soluble HLA-G protein are elevated during mid-gestation and decreased in pre-eclampsia. ---
25  2011 Plasma soluble human leukocyte antigen-G expression is a potential clinical biomarker in patients with hepatitis B virus infection. AHB, CHB, HBV, RHB, ROC
26  2011 Serum sHLA-G levels: a useful indicator in distinguishing colorectal cancer from benign colorectal diseases. ROC
27  2010 Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease. IL
28  2010 Differences in the soluble HLA-G blood serum concentration levels in patients with ovarian cancer and ovarian and deep endometriosis. ---
29  2010 [Effectiveness of intravenous immunoglobulin therapy in treating unexplained recurrent spontaneous abortion and its effect on the level of serum soluble human leucocyte antigen G]. ELISA, IL-10, IL-2, IVIG, URSA
30  2009 Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammation. AF, IAI, PROM, PTL
31  2009 How to predict implantation? No correlation between embryonic aneuploidy and soluble human leukocyte antigen G-concentrations. ELISA, IVF, PGD
32  2009 Soluble HLA-G in IVF/ICSI embryo culture supernatants does not always predict implantation success: a multicentre study. ART, ES
33  2009 Soluble HLA-G regulates motility and invasion of the trophoblast-derived cell line SGHPL-4. EGF, EVT, HGF, SGHPL-4sG1, TNF
34  2008 Symposium: innovative techniques in human embryo viability assessment. Soluble human leukocyte antigen-G and pregnancy success. ICSI
35  2008 The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. ---
36  2007 Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders. IFN-gamma, IL-2, NHL
37  2007 Graduated Embryo Score and soluble human leukocyte antigen-G expression improve assisted reproductive technology outcomes and suggest a basis for elective single-embryo transfer. ART, GES
38  2007 Quantification and identification of soluble HLA-G isoforms. beta2m, ELISA, mAb
39  2006 Secretion of soluble HLA-G by day 3 human embryos associated with higher pregnancy and implantation rates: assay of culture media using a new ELISA kit. ---
40  2006 Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages. ALL, HLA-G
41  2005 Embryonic soluble HLA-G as a marker of developmental potential in embryos. ELISA
42  2005 Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004. ELISA, mAb
43  2005 [Expression of soluble human leukocyte antigen G and its relationship to embryo development]. ---
44  2004 Expression of sHLA-G in supernatants of individually cultured 46-h embryos: a potentially valuable indicator of 'embryo competency' and IVF outcome. ICSI, IR
45  2003 Soluble HLA-G molecules are increased in lymphoproliferative disorders. ---
46  2002 [Relationship between trophoblast cell's human leukocyte antigen G expression and early embryo development]. IVF-ET